“…Numerous trials have demonstrated compelling decreases in turnaround time, and it is often assumed this translates to improvements in disposition time, ED LOS, patient satisfaction, cost, time to treatment, and clinical outcome 14,15,17–29 . For example, in ACS management, ED point‐of‐care testing has been suggested to not only reduce time to test results, 14,23,30,31 but also to offer the advantages of no interruption in the clinical decision making process and reductions in LOS 18 .…”